CTChuanjian Tu

Chuanjian Tu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chuanjian Tu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Conditional survival patterns and individualized prognostic prediction in solitary plasmacytoma of the spine

    by Zhiwei Gu, Zhihao Yang, Jiajie Xia, Chuanjian Tu

    Background: Solitary plasmacytoma of the spine (SPS) is a rare plasma cell neoplasm with limited survival data and prognostic tools. Conditional survival (CS) analysis provides time-dependent survival estimates that may better reflect the evolving prognosis of cancer patients. This study aimed to explore prognostic factors and construct a CS-based nomogram for SPS. Methods: We extracted SPS cases from the SEER database. CS analysis was performed to evaluate dynamic survival probabilities. Multivariate Cox regression identified factors significantly associated with overall survival (OS). To optimize variable selection, we integrated least absolute shrinkage and selection operator (LASSO) regression and best subset regression (BSR) with stepwise backward Cox analysis. The final variables were used to construct a CS-based nomogram, which was validated for discrimination, calibration, and risk stratification ability. Results: A total of 1660 patients were included. CS estimates showed that survival probabilities improved significantly with each additional year survived after diagnosis. Age, radiotherapy, chemotherapy, household income, and marital status were independent predictors of OS, whereas surgical resection showed no significant association with prognosis. Notably, chemotherapy use was associated with poorer survival. The combined BSR–LASSO–stepwise Cox approach selected age, radiotherapy, and marital status for the final model. The nomogram demonstrated strong predictive performance and effectively stratified patients into distinct risk groups. Conclusion: We developed and validated the first CS-based prognostic nomogram for SPS, incorporating age, radiotherapy, and marital status. This model demonstrated promising predictive performance in internal validation and may serve as a foundation for future external validation and clinical application in this rare malignancy.

  • Open Access

    How survival time reshapes prognostic risk in giant cell glioblastoma

    by Xiaoling Zhang, Jiajie Xia, Hua Huang, Chuanjian Tu, Zhihao Yang

    To address the lack of dynamic prognostic tools for the rare Giant Cell Glioblastoma (gcGBM), this study utilized conditional survival (CS) analysis and a population-based nomogram to provide evolving, personalized survival estimates beyond baseline diagnosis. We identified 490 patients with gcGBM from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2022). The cohort was split into training (n = 343) and validation (n = 147) sets. Conditional survival probabilities-CS(t|s) = S(t + s)/S(s)-were calculated to assess the likelihood of surviving an additional t years given s years already survived. A Random Survival Forest with Recursive Feature Elimination (RSF-RFE) algorithm was employed to select the most parsimonious predictors. A CS-nomogram was constructed and evaluated using calibration curves, time-dependent AUC, and Decision Curve Analysis (DCA). An interactive web-based calculator was also developed. The baseline 5-year overall survival (OS) was 14%. However, CS analysis revealed that the prognosis improved significantly over time: for patients who survived 3 years, the probability of surviving to year 5 rose to 69%, and reached 83% for those surviving to year 4. The RSF-RFE identified six key predictors: age, sex, tumor site, surgery, radiotherapy, and chemotherapy. The resulting CS-nomogram demonstrated high discriminatory power and clinical net benefit in both cohorts. Risk stratification effectively distinguished high-risk and low-risk groups. Prognosis in gcGBM is a dynamic process. The risk of mortality is highest in the early years post-diagnosis but decreases substantially for long-term survivors. Our validated CS-nomogram and web-based tool provide clinicians with a practical means to offer personalized, time-adjusted survival estimates, facilitating better patient counseling and refined follow-up strategies.

  • Open Access

    Multiphase CTA Collateral Score to Identify Intracranial Atherosclerotic Stenosis-Related Large Vessel Occlusion

    by Jiajie Xia, Chuanjian Tu, Hui Qian, Zhiwei Gu, Dagang Song, Lei Xu

    Objective: Identification of acute ischemic stroke with large vessel occlusion (AIS-LVO) etiology is crucial for effective revascularization therapy. As collaterals are pivotal in maintaining cerebral perfusion in intracranial atherosclerotic stenosis (ICAS), we investigated whether multiphase CT angiography (mCTA) collateral score can be a diagnosis marker of ICAS-related LVO. Methods: We reviewed clinical and imaging data from 92 patients who presented with AIS-LVO and underwent mCTA (57 ICAS-related LVO and 35 embolic LVO). Logistic regression was used to identify ICAS-related LVO. The diagnostic accuracy of the mCTA collateral score for identifying ICAS-related LVO was determined using receiver operating characteristic (ROC) analysis. Results: Compared with patients with embolic LVO, those with ICAS-related LVO had a high median mCTA collateral score (4 vs. 3; PPPP=0.0464). Conclusions: The mCTA collateral score may be associated with ICAS-related LVO and could be beneficial in identifying the etiology of AIS-LVO.